189 related articles for article (PubMed ID: 34290337)
21. Pilot study of acupuncture for the treatment of joint symptoms related to adjuvant aromatase inhibitor therapy in postmenopausal breast cancer patients.
Crew KD; Capodice JL; Greenlee H; Apollo A; Jacobson JS; Raptis G; Blozie K; Sierra A; Hershman DL
J Cancer Surviv; 2007 Dec; 1(4):283-91. PubMed ID: 18648963
[TBL] [Abstract][Full Text] [Related]
22. Knee osteoarthritis pain in the elderly can be reduced by massage therapy, yoga and tai chi: A review.
Field T
Complement Ther Clin Pract; 2016 Feb; 22():87-92. PubMed ID: 26850812
[TBL] [Abstract][Full Text] [Related]
23. Electroacupuncture for fatigue, sleep, and psychological distress in breast cancer patients with aromatase inhibitor-related arthralgia: a randomized trial.
Mao JJ; Farrar JT; Bruner D; Zee J; Bowman M; Seluzicki C; DeMichele A; Xie SX
Cancer; 2014 Dec; 120(23):3744-51. PubMed ID: 25077452
[TBL] [Abstract][Full Text] [Related]
24. Ageing perceptions and non-adherence to aromatase inhibitors among breast cancer survivors.
Brier MJ; Chambless DL; Chen J; Mao JJ
Eur J Cancer; 2018 Mar; 91():145-152. PubMed ID: 29329697
[TBL] [Abstract][Full Text] [Related]
25. Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors.
Chim K; Xie SX; Stricker CT; Li QS; Gross R; Farrar JT; DeMichele A; Mao JJ
BMC Cancer; 2013 Sep; 13():401. PubMed ID: 24004677
[TBL] [Abstract][Full Text] [Related]
26. Effect of neuromuscular taping on musculoskeletal disorders secondary to the use of aromatase inhibitors in breast cancer survivors: a pragmatic randomised clinical trial.
Conejo I; Pajares B; Alba E; Cuesta-Vargas AI
BMC Complement Altern Med; 2018 Jun; 18(1):180. PubMed ID: 29890985
[TBL] [Abstract][Full Text] [Related]
27. Adaptation of an Evidence-Based Arthritis Program for Breast Cancer Survivors on Aromatase Inhibitor Therapy Who Experience Joint Pain.
Nyrop KA; Callahan LF; Rini C; Altpeter M; Hackney B; Schecher A; Wilson A; Muss HB
Prev Chronic Dis; 2015 Jun; 12():E91. PubMed ID: 26068412
[TBL] [Abstract][Full Text] [Related]
28. Interventions for the Treatment of Aromatase Inhibitor-Associated Arthralgia in Breast Cancer Survivors: A Systematic Review and Meta-analysis.
Yang GS; Kim HJ; Griffith KA; Zhu S; Dorsey SG; Renn CL
Cancer Nurs; 2017; 40(4):E26-E41. PubMed ID: 27333128
[TBL] [Abstract][Full Text] [Related]
29. A randomised trial of electro-acupuncture for arthralgia related to aromatase inhibitor use.
Mao JJ; Xie SX; Farrar JT; Stricker CT; Bowman MA; Bruner D; DeMichele A
Eur J Cancer; 2014 Jan; 50(2):267-76. PubMed ID: 24210070
[TBL] [Abstract][Full Text] [Related]
30. Randomized Multicenter Placebo-Controlled Trial of Omega-3 Fatty Acids for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain: SWOG S0927.
Hershman DL; Unger JM; Crew KD; Awad D; Dakhil SR; Gralow J; Greenlee H; Lew DL; Minasian LM; Till C; Wade JL; Meyskens FL; Moinpour CM
J Clin Oncol; 2015 Jun; 33(17):1910-7. PubMed ID: 25940724
[TBL] [Abstract][Full Text] [Related]
31. Arthralgia induced by endocrine treatment for breast cancer: A prospective study of serum levels of insulin like growth factor-I, its binding protein and oestrogens.
Lintermans A; Vanderschueren D; Verhaeghe J; Van Asten K; Jans I; Van Herck E; Laenen A; Paridaens R; Billen J; Pauwels S; Vermeersch P; Wildiers H; Christiaens MR; Neven P
Eur J Cancer; 2014 Nov; 50(17):2925-31. PubMed ID: 25304297
[TBL] [Abstract][Full Text] [Related]
32. Exercise intervention in breast cancer patients with aromatase inhibitor-associated arthralgia: a pilot study.
DeNysschen CA; Burton H; Ademuyiwa F; Levine E; Tetewsky S; O'Connor T
Eur J Cancer Care (Engl); 2014 Jul; 23(4):493-501. PubMed ID: 24289215
[TBL] [Abstract][Full Text] [Related]
33. Patterns and risk factors associated with aromatase inhibitor-related arthralgia among breast cancer survivors.
Mao JJ; Stricker C; Bruner D; Xie S; Bowman MA; Farrar JT; Greene BT; DeMichele A
Cancer; 2009 Aug; 115(16):3631-9. PubMed ID: 19517460
[TBL] [Abstract][Full Text] [Related]
34. Aromatase inhibitor-associated arthralgia syndrome.
Burstein HJ
Breast; 2007 Jun; 16(3):223-34. PubMed ID: 17368903
[TBL] [Abstract][Full Text] [Related]
35. Time course of arthralgia among women initiating aromatase inhibitor therapy and a postmenopausal comparison group in a prospective cohort.
Castel LD; Hartmann KE; Mayer IA; Saville BR; Alvarez J; Boomershine CS; Abramson VG; Chakravarthy AB; Friedman DL; Cella DF
Cancer; 2013 Jul; 119(13):2375-82. PubMed ID: 23575918
[TBL] [Abstract][Full Text] [Related]
36. Effects of the Chinese medicine Yi Shen Jian Gu granules on aromatase inhibitor-associated musculoskeletal symptoms: A randomized, controlled clinical trial.
Peng N; Yu M; Yang G; Fu Q; Xu Y; Yu J; Liu Q; Li C; Xu W; Zhang Y; Ma C; Yang L; Yu R; Wang X
Breast; 2018 Feb; 37():18-27. PubMed ID: 29059538
[TBL] [Abstract][Full Text] [Related]
37. Improving Adherence to Endocrine Therapy in Women With HR-Positive Breast Cancer.
Brockway JP; Shapiro CL
Oncology (Williston Park); 2018 May; 32(5):235-7, 249. PubMed ID: 29847854
[TBL] [Abstract][Full Text] [Related]
38. A Telehealth-Delivered Tai Chi Intervention (TaiChi4Joint) for Managing Aromatase Inhibitor-Induced Arthralgia in Patients With Breast Cancer During COVID-19: Longitudinal Pilot Study.
Gomaa S; West C; Lopez AM; Zhan T; Schnoll M; Abu-Khalaf M; Newberg A; Wen KY
JMIR Form Res; 2022 Jun; 6(6):e34995. PubMed ID: 35727609
[TBL] [Abstract][Full Text] [Related]
39. Aromatase inhibitor associated arthralgia: the importance of oncology provider-patient communication about side effects and potential management through physical activity.
Nyrop KA; Callahan LF; Rini C; Altpeter M; Hackney B; DePue A; Wilson A; Schechter A; Muss HB
Support Care Cancer; 2016 Jun; 24(6):2643-50. PubMed ID: 26757739
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness, safety, and economic evaluation of adjuvant moxibustion therapy for aromatase inhibitor-induced arthralgia of postmenopausal breast cancer stage I to III patients: Study protocol for a prospective, randomized, assessor-blind, usual-care controlled, parallel-group, pilot clinical trial.
Shin S; Jang BH; Park SH; Lee JW; Chae MS; Kim N; Suh HS; Han S; Min SY; Baek SK; Lim YJ; Hwang DS
Medicine (Baltimore); 2019 Sep; 98(38):e17260. PubMed ID: 31568000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]